Your search for major depressive disorder returned 4 results

Solanezumab is a humanized monoclonal antibody designed to increase clearance of soluble amyloid beta (Aβ) from the brain by binding to aggregated forms of Aβ.

According to a new poll, more than 90% of adults who reported they get good sleep were also free of depressive symptoms.

Being physically active at any point during adulthood is associated with a higher later-life cognitive state.

Inpatients with schizophrenia spectrum disorders were randomly assigned to receive treatment as usual with or without a yoga-based group intervention for 4 weeks.